New Product Development
The global alcohol use disorder treatment market was worth US$ 700 million in 2023 and is expected to be worth US$ 1,300 million by 2033, growing at a CAGR of 6.4% between 2023 and 2033. The increased prevalence of alcohol abuse and binge drinking is expected to fuel the industry. This disease knows no bounds …
Continue reading “Alcohol Use Disorder Treatment Market to expand at a 6.4% value CAGR by 2033”
According to Future Market Insights’ newly released Biosensors Market analysis report, the global market size of the Biosensors Market in 2022 will be US$ 24.5 Billion. The projected market growth is expected to be significantly higher than the historical growth, with a CAGR of 9.5% from 2023 to 2033. Medical biosensors are expected to be …
Continue reading “Biosensors Market is projected to witness a CAGR of 9.5% from 2023 to 2033”
The global clostridium diagnostics market is projected to secure US$ 7.8 Billion by 2032 while recording a CAGR of 12.2% during the forecast period. The growth of the market can be attributed to the growing prevalence of clostridium-related diseases and the growing awareness campaigns launched by various authorities. There has been an increased focus of players in the market …
Continue reading “Clostridium Diagnostics Market to reach US$ 7.8 Billion by 2032 | FMI”
Dementia Care Products Market: Region-wise Outlook Geographically, North America is the leading consumer driven market for dementia care products because of the large number of product suppliers in the region as well as product affordability in the region. This is followed by Western Europe region due to high disposable income as well as consumption trend …
The Bioactive Coating Devices Market is predicted to be worth US$ 307.45 Million in 2022 and US$ 695.13 million by 2032. During the forecast period, demand for bioactive coating devices is expected to expand at an 8.5% CAGR. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, …
Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow are damaged. This damage leads to low numbers of one or more type of blood cells. MDS is considered as a type of cancer. Myelodysplastic syndromes are a rare group of disorders in which body no longer makes enough healthy …
The global PD-L1 biomarker testing market size was valued at US$ 541.6 Mn in 2021 and is expected to exhibit a CAGR of close to 9.4% over the forecast period (2022-2032). Increasing incidence of cancer across the globe is underpinning the need for advanced cancer diagnosis equipment, which is expected to boost the market in the forthcoming years. Cancer immunotherapy is …
[289 Pages Report] A recently published study by FMI expects the global arterial cannula market to augment at a 6.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 40 Billion is expected for the market. The rising frequency of chronic diseases necessitating cardiopulmonary bypass surgery (CABG), dialysis, and …
[250 Pages Report] The Terminal Sterilization Services Market revenues were estimated at US$ 9.1 Bn in 2021 and is anticipated to grow at a CAGR of 12.7% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach a valuation of US$ 33.5 Bn. Attribute Details Global …
[309 Pages Report] The near-patient molecular solutions market is estimated to register a magnificent CAGR of 8% during the forecast period. According to FMI, the market is projected at US$ 7.56 Bn by 2033, up from US$ 3.5 Bn in 2023. The increasing prevalence of diseases such as diabetes and cardiac diseases is increasing the adoption of near-patient molecular solutions for effective treatment …
